G01N 33/5436
With ligand physically entrapped within the solid phase
Official title: {with ligand physically entrapped within the solid phase (liposomes G01N33/5432; immunological test elements G01N33/54386)}
G01N33/5436 (With ligand physically entrapped within the solid phase) appears on 183 US grants and 250 published applications in this corpus.
Search patents in G01N- Granted patents
- 183
- Published applications
- 250
- Assignees
- 176
- Inventors
- 568
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 5 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 6 | 2 |
| 2002 | 3 | 3 |
| 2003 | 1 | 9 |
| 2004 | 3 | 11 |
| 2005 | 4 | 17 |
| 2006 | 3 | 3 |
| 2007 | 3 | 4 |
| 2008 | 3 | 4 |
| 2009 | 3 | 8 |
| 2010 | 1 | 10 |
| 2011 | 4 | 4 |
| 2012 | 5 | 11 |
| 2013 | 5 | 6 |
| 2014 | 4 | 12 |
| 2015 | 5 | 9 |
| 2016 | 4 | 14 |
| 2017 | 7 | 11 |
| 2018 | 10 | 14 |
| 2019 | 12 | 16 |
| 2020 | 10 | 25 |
| 2021 | 13 | 15 |
| 2022 | 14 | 9 |
| 2023 | 11 | 8 |
| 2024 | 7 | 15 |
| 2025 | 7 | 7 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immunoadsorbent and composite affinity column for purifying fumonisins B1, anguidin, T-2 toxin, zearalenone and vomitoxin, method for detecting the same, and preparation method of composite affinity column21 Jul 2026US 12,687,539 B2Oil Crops Research Institute, Chinese Academy of Agricultural Sciences
- Compartmentalized assays of bispecific and multispecific biologics30 Dec 2025US 12,510,535 B2Amberstone Biosciences, Inc.
- Sorbent composition for pre-analytical treatment of samples9 Dec 2025US 12,492,974 B2Immundiagnostik AG
- Methods for forming a matrix for receiving tissue samples9 Dec 2025US 12,493,030 B2Leavitt Medical, Inc.
- Compositions and methods for molecular labeling4 Nov 2025US 12,461,094 B2Bio-Rad Laboratories, Inc.
- Compositions and methods for three-dimensional spatial biomolecule identity and abundance assessment3 Sep 2026US 2026/0259202 A1The Regents of the University of California
- Compositions and methods for molecular labeling6 Aug 2026US 2026/0227387 A1Bio-Rad Laboratories, Inc.
- Compositions and methods for molecular labeling5 Feb 2026US 2026/0036574 A1Bio-Rad Laboratories, Inc.
- Apoptotic cell mimic27 Nov 2025US 2025/0362292 A1Slingshot Biosciences, Inc.
- Method of determining the presence and/or amount of target molecules13 Nov 2025US 2025/0347695 A1Zellkraftwerk GmbH
Most cited
By later US patents
- Needle-less injector369US 5,480,381 AWeston Medical Limited · 1996
- Partitioning and processing of analytes and other species361US 9,644,204 B210x Genomics, Inc. · 2017
- Secretions of proteins by encapsulated cells306US 6,806,058 B2One Cell Systems, Inc. · 2004
- Polynucleotide barcode generation238US 9,388,465 B210x Genomics, Inc. · 2016
- Compositions and methods for molecular labeling141US 9,150,852 B2Raindance Technologies, Inc. · 2015